Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.8 USD | -3.93% | -5.88% | -38.50% |
Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M | MT |
Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26 | MT |
Financials (USD)
Sales 2024 * | 101M | Sales 2025 * | 113M | Capitalization | 167M |
---|---|---|---|---|---|
Net income 2024 * | -18M | Net income 2025 * | -12M | EV / Sales 2024 * | 1.65 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.48 x |
P/E ratio 2024 * |
-11.5
x | P/E ratio 2025 * |
-17
x | Employees | 136 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.15% |
Latest transcript on OptimizeRx Corporation
1 day | +2.46% | ||
1 week | -3.88% | ||
Current month | -24.61% | ||
1 month | -20.14% | ||
3 months | -38.48% | ||
6 months | +9.44% | ||
Current year | -35.99% |
Managers | Title | Age | Since |
---|---|---|---|
Will Febbo
CEO | Chief Executive Officer | 55 | 16-02-21 |
Edward Stelmakh
DFI | Director of Finance/CFO | 58 | 21-10-10 |
President | 46 | 19-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Wasson
BRD | Director/Board Member | 65 | 20-07-20 |
Catherine Klema
BRD | Director/Board Member | 65 | Jan. 23 |
Patrick Spangler
BRD | Director/Board Member | 68 | 18-03-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 8.8 | -3.93% | 140 617 |
24-04-24 | 9.16 | +2.46% | 144,870 |
24-04-23 | 8.94 | -1.65% | 149,534 |
24-04-22 | 9.09 | -2.47% | 213,898 |
24-04-19 | 9.32 | -0.32% | 298,861 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.99% | 167M | |
+15.60% | 409B | |
+12.65% | 144B | |
+19.61% | 103B | |
+14.45% | 82.83B | |
+49.66% | 55.78B | |
+28.18% | 51.21B | |
+5.22% | 37.55B | |
+17.51% | 32.28B | |
-11.31% | 22.42B |
- Stock Market
- Equities
- OPRX Stock